학술논문
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
Document Type
Article
Author
Marin, D.; Li, Y.; Basar, R.; Rafei, H.; Daher, M.; Nieto, Y.; Uprety, N.; Acharya, S.; Liu, E.; Wilson, J.; Banerjee, P.; Ganesh, C.; Ammari, M.; Rao, S.; Shanley, M.; Kaplan, M.; Hosing, C.; Kebriaei, P.; Moseley, S.M.; Lin, P.; Ang, S.; Popat, U.R.; Qazilbash, M.H.; Champlin, R.E.; Shpall, E.J.; Rezvani, K.; Dou, J.; Mohanty, V.; Dede, M.; Chen, K.; Macapinlac, H.A.; Thall, P.F.; Bassett, R.; Cao, K.; Nastoupil, L.J.; Flowers, C.R.
Source
In: Nature Medicine . (Nature Medicine, March 2024, 30(3):772-784)
Subject
Language
English
ISSN
1546170X
10788956
10788956